Lin Shen to HIV-1
This is a "connection" page, showing publications Lin Shen has written about HIV-1.
Connection Strength
1.344
-
A novel method for determining the inhibitory potential of anti-HIV drugs. Trends Pharmacol Sci. 2009 Dec; 30(12):610-6.
Score: 0.319
-
Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection. J Allergy Clin Immunol. 2008 Jul; 122(1):22-8.
Score: 0.289
-
Dose-response curve slope is a missing dimension in the analysis of HIV-1 drug resistance. Proc Natl Acad Sci U S A. 2011 May 03; 108(18):7613-8.
Score: 0.088
-
Consistent inhibition of HIV-1 replication in CD4+ T cells by acyclovir without detection of human herpesviruses. J Virol. 2011 May; 85(9):4618-22.
Score: 0.087
-
Discovery of entry inhibitors for HIV-1 via a new de novo protein design framework. Biophys J. 2010 Nov 17; 99(10):3445-53.
Score: 0.085
-
Unstimulated primary CD4+ T cells from HIV-1-positive elite suppressors are fully susceptible to HIV-1 entry and productive infection. J Virol. 2011 Jan; 85(2):979-86.
Score: 0.085
-
New approaches for quantitating the inhibition of HIV-1 replication by antiviral drugs in vitro and in vivo. Curr Opin Infect Dis. 2009 Dec; 22(6):574-82.
Score: 0.080
-
Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation. Proc Natl Acad Sci U S A. 2009 Apr 14; 106(15):6321-6.
Score: 0.076
-
Preferential cytolysis of peripheral memory CD4+ T cells by in vitro X4-tropic human immunodeficiency virus type 1 infection before the completion of reverse transcription. J Virol. 2008 Sep; 82(18):9154-63.
Score: 0.072
-
Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle. Proc Natl Acad Sci U S A. 2008 Mar 25; 105(12):4832-7.
Score: 0.071
-
The HBV drug entecavir - effects on HIV-1 replication and resistance. N Engl J Med. 2007 Jun 21; 356(25):2614-21.
Score: 0.067
-
A quantitative basis for antiretroviral therapy for HIV-1 infection. Nat Med. 2012 Feb 19; 18(3):446-51.
Score: 0.023